Tarnagulla Ventures

Active

Updated: Apr 1, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jul 1, 2018	Inversago Pharma	$7.0M Series A	Amorchem, Jamie Stiff	Forbion, Ed Mathers, Accel-Rx Health Sciences Accelerator, Anges Québec, Anges Québec Capital, JDRF T1D Fund

Total Raised

N/A

Valuation

N/A